Definitions and outcomes reported in studies investigating the management of new onset atrial fibrillation in acutely unwell patients admitted to the intensive care unit: a scoping review
Johnston BW, et al. European Heart Journal Open, 2026.
New-onset atrial fibrillation (NOAF) is common in critically ill patients, yet definitions and outcome reporting vary widely across studies. This scoping review systematically mapped how NOAF is defined and which outcomes are measured across 44 studies, finding substantial heterogeneity. The findings highlight the need for a Core Outcome Set to standardise future NOAF research.
Management of new onset atrial fibrillation in critically unwell adult patients: a systematic review and narrative synthesis
Johnston BW, et al. British Journal of Anaesthesia, 2022.
This systematic review evaluated pharmacological and non-pharmacological strategies for managing NOAF in critically unwell patients, including 30 studies. It reports cardioversion rates for treatments such as direct current cardioversion, amiodarone and beta-blockers. Significant heterogeneity between studies limited direct comparison, underlining the need for standardised trials.
Development of Core Outcome Sets for trials on the management of Atrial fiBrillAtion in Critically Unwell patientS (COS-ABACUS): a protocol
Johnston BW, et al. BMJ Open, 2023.
This protocol sets out the methodology for COS-ABACUS, which aims to develop an internationally agreed Core Outcome Set for trials on managing NOAF during critical illness. It describes a five-stage process involving stakeholders including clinicians and patients, using systematic review and an e-Delphi consensus method.